Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Champions Oncology, Inc.

Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins oncologist that was named by TIME as one of the top physicians and scientists in the United States in 2001.

Investment goal date:
Dividends reinvested
Champions Oncology, Inc. CSBR report Q1 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q3 2017
2018-03-14
--
--
Q2 2017
2017-11-29
--
--
Q1 2017
2017-09-14
0.0000
-0.0600
Q4 2016
2017-07-27
0.0000
-0.2200
Q3 2016
2017-03-16
0.0000
-0.1300
Q2 2016
2016-11-29
0.0000
-0.0500
Q1 2016
2016-09-09
0.0000
-0.2600
Q4 2015
2016-07-28
0.0000
-0.3000
Q3 2015
2016-03-15
0.0000
-0.2800
Q2 2015
2015-12-14
0.0000
-0.2900
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
ACADIAN ASSET MANAGEMENT LLC
5416
BANK OF AMERICA CORP /DE/
2144
Battery Partners IX, LLC
1953549
Commonwealth Equity Services, Inc
16653
GRT CAPITAL PARTNERS LLC
24064
JPMORGAN CHASE & CO
2500
MORGAN STANLEY
3500
NEA Management Company, LLC
1562500
PERCEPTIVE ADVISORS LLC
366972
SABBY MANAGEMENT, LLC
71700
Sandy Spring Bank
8333
Spark Investment Management LLC
40200
UBS Group AG
4267
Vanguard Group, Inc
74832
Veritas Investment Management (UK) Ltd
2083
Major Shareholders
Name Relationship
Total Shares
Holding stocks